Understanding FDA regulation of DTC genetic tests within the context of administrative law

American Journal of Human Genetics

Volumn 87, Issue 4, 2010, Pages 451-456

  Wagner, Jennifer K ^a  

^a DUKE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONSUMER; CONSUMER ADVOCACY; FOOD AND DRUG ADMINISTRATION; GENETIC SCREENING; GENETICS; GENOTYPE; LAW; MARKETING; NOTE; PRIORITY JOURNAL; UNITED STATES; GOVERNMENT REGULATION; LEGISLATION AND JURISPRUDENCE; PRODUCT SAFETY;

CONSUMER PRODUCT SAFETY; GENETIC TESTING; GOVERNMENT REGULATION; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 77957739460     PISSN: 00029297     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajhg.2010.09.003     Document Type: Note

References (71)

1. FDA. (2010). Oversight of laboratory-developed tests (LDTs). http://www.fda.gov/MedicalDevices/NewsEvents/WorkshopsConferences/ucm212830.htm.
2. U.S. Government Accountability Office (GAO). (2006). GAO 10-847T. http://energycommerce.house.gov/documents/20100722/Kutz.Testimony.07.22.2010. pdf.
3. House Committee on Energy and Commerce Subcommittee. (2010). Direct to Consumer Genetic Testing and Consequences to the Public Health. http://energycommerce.house.gov/index.php?option=com-content&view= article&id=2083:hearing-on-direct-to-consumer-genetic-testing-and-the- consequences-to-the-public-health&catid=133:subcommittee-on-oversight-and- investigations&Itemid=73.
4. S. Hogarth Public Health Genomics 13 2010 322 326
5. L.B. Solberg Vanderbilt Journal of Entertainment and Technology Law 11 2010 no. 711
6. C.F.C. Jordens, I.H. Kerridge, and G.N. Samuel Amer.J. Bioethics 9 2009 13 15
7. S.S. Lee, S. Soo-Jin Lee, D.A. Bolnick, T. Duster, P. Ossorio, and K. Tallbear Science 325 2009 38 39
8. J. Kaye The regulation of direct-to-consumer genetic tests Hum. Mol. Genet. 17 no. R2 2008 R180 R183
9. S. Hogarth, G. Javitt, and D. Melzer Annu. Rev. Genomics Hum. Genet. 9 2008 161 182
10. NIH. (2010). NIH announces Genetic Testing Registry (GTR). www.nih.gov/news/health/mar2010/od-18.htm.
11. Sec'y's Advisory Committee on Genetics, Health and Society. (2010). Direct-to-Consumer Genetic Testing. http://oba.od.nih.gov/oba/SACGHS/reports/ SCAGHS-DTC-report-2010.pdf.
12. Kutz, G. (2010). Testimony before the Subcommittee on Oversight and Investigations, Committee on Energy and Commerce, House of Representatives. http://www.gao.gov/new.items/d10847t.pdf.
13. U.S. Const. Art. I., Sec. 1.
14. U.S. Const. Art. I., Sec. 8.
15. U.S. Const. Art. III, Sec. 1.
16. Schor v. CFTC (1986). 478 U.S. 833.
17. Bimetallic v. State Board of Equalization (1915). 239 U.S. 441.
18. Londoner v. Denve (1908). 210 U.S. 373.
19. Administrative Procedure Act, 5 U.S.C. §551(4-7).
20. SEC v. Chenery (1947). 332 U.S. 194.
21. Administrative Procedure Act, 5 U.S.C. §553.
22. Administrative Procedure Act, 5 U.S.C. §§553(c), 556, 557.
23. Administrative Procedure Act, 5 U.S.C. §554, 556, 557.
24. Administrative Procedure Act, 5 U.S.C. §559.
25. J.W. Hampton, Jr. & Co. v. United States (1928). 276 U.S. 394, 409, 48 S. Ct. 348.
26. Whitman v. American Trucking Associations (2001). 531 U.S. 457, 475, 121 S. Ct. 903, 913.
27. Panama Refining Co. v. Ryan (1935). 293 U.S. 388, 55 S.Ct. 241.
28. A.L.A. Schecter Poultry Corp. v. United States (1935). 295 U.S. 495, 55 S. Ct. 837.
29. Administrative Procedure Act, 5 U.S.C. § 702.
30. Administrative Procedure Act, 5 U.S.C. §706(2)(A).
31. Motor Veh. Mfrs. Ass'n v. State Farm Insurance (1983). 463 U.S. 29.
32. Chevron U.S.A., Inc. v. Natural Resources Defence Council, Inc. (1984). 467 U.S. 837.
33. Sanofi-Aventis v. Food and Drug Administration (2010). -F.Supp.2d-, 2010 WL 2899014, 3 (D.D.C. 2010) (internal citations omitted).
34. MCI Telecommunications. Corp. v. AT&T Co. (1994). 512 U.S. 218.
35. United States v. Mead Corp. (2001). 533 U.S. 218.
36. -21 U.S.C. §301-395.
37. FDA. How did the Federal Food, Drug, and Cosmetic Act come about? http://www.fda.gov/AboutFDA/Basics/ucm214416.htm.
38. FDA. (2010). When and Why was FDA Formed? http://www.fda.gov/AboutFDA/ Basics/ucm214403.htm.
39. K. Paul-Emile Cornel Journal of Law and Public Policy 19 2010 691 740
40. B.J. Evans Notre Dame Law Review 85 2010 419 524
41. -21 U.S.C. §360c et seq.
42. In re Orthopedic Bone Screw Products Liability Litigation, not reported in F. Supp. 2d, 1999 WL 455667, 1 (E.D. Pa. 1999) (citing S. Rep. No. 94-33, at 5 (1975), reprinted in 1976 U.S.C.C.A.N. 1070, 1075).
43. Wyeth Holdings Corporation v. Sebelius (2010). 603 F.3d 1291 (U.S.).
44. Riegel v. Medtronics, Inc. (2008). 552 US 312, 328, 128 S.Ct. 999, 1010.
45. Smoking Everywhere, Inc. v. U.S. Food and Drug Admin. (2010). 68 F. Supp. 2d 62, 69 (D.D.C.).
46. Wyeth v. Levine (2009). 129 S. Ct. 1187 (U.S. Vt.).
47. Yale-New Haven Hosp. v. Leavitt (2006). 470 F.3d 71, 79 (C.A.2 [Conn.]).
48. A.S. Robertson Berkeley Technol. Law J. 24 2009 213
49. Javitt, G.H. (2007). Food Drug Law J. 62, 617-652. http://www.dnapolicy. org/resources/Javitt-FDLJ.pdf.
50. Kazon, Peter M. (2010). Medical Devices law & Industry Report, 4 MELR 619.
51. Vorhaus, D. (2010). Genomics Law Report. http://www.genomicslawreport. com/index.php/2010/07/15/personal-genomics-goes-to-washington/
52. FDA. Draft Guidance for Industry, Clinical Laboratories, and FDA Staff - In Vitro Diagnostic Multivariate Index Assays http://www.fda.gov/MedicalDevices/ DeviceRegulationandGuidance/GuidanceDocuments/ucm079148.htm.
53. Lakhman, K. 2010. Final IVDMIA Rule Was 'Imminent' This Month, But Now is At Least 90 Days Away. http://www.genomeweb.com/blog/final-ivdmia-rule-was- imminent-month-now-least-90-days-away.
54. Vorhaus, D. (2010). Genomics Law Report http://www.genomicslawreport.com/ index.php/2010/06/15/challenging-the-fda-a-history-lesson-for-dtc-genetics/
55. FDA Shelves IVDMIA Final Guidelines in Order to Focus on Overall LDT Regulation. http://www.genomeweb.com/dxpgx/fda-shelves-ivdmia-final-guidelines- order-focus-overall-ldt-regulation.
56. Vorhaus, D. (2010). Genomics Law Report. http://www.genomicslawreport. com/index.php/2010/06/16/breaking-fda-moves-to-broadly-regulate-ldts/
57. FDA. (2010). Oversight of Laboratory Developed Tests; Public Meeting; Request for Comments; F.R. 2010-14654. http://edocket.access.gpo.gov/2010/2010- 14654.htm.
58. FDA/CDRH Public Meeting. Oversight of Laboratory Developed Tests (LDTs), Date July 19-20, 2010. http://www.fda.gov/MedicalDevices/NewsEvents/ WorkshopsConferences/ucm212830.htm.
59. Shuren, J. (2010). Direct to Consumer Genetic Testing and Consequences to the Public, www.fda.gov/NewsEvents/Testimony/ucm219925.htm
60. A.L. Beaudet Nature 466 2010 816 817
61. G. Javitt Nature 466 2010 817 818
62. J.P. Annes, M.A. Giovanni, and M.F. Murray Risks N. Engl. J. Med. 363 2010 1100 1101
63. J.P. Evans, D.C. Dale, and C. Fomous N. Engl. J. Med. 363 2010 1099 1103
64. J.Z. Hines, P. Lurie, E. Yu, and S. Wolfe PLoS Med. 7 2010 e1000280
65. B. Patsner Houst. J. Health Law Policy 237 2009 246
66. Secretary's Advisory Committee On Genetic Testing (SACGT). http://oba.od.nih.gov/oba/sacgt/reports/Addendum-final.pdf.
67. FDA 510k Working Group (2010). CDRH Preliminary Internal Evaluations - Volume I, http://www.fda.gov/downloads/AboutFDA/CentersOffices/CDRH/CDRHReports/ UCM220784.pdf.
68. Secretary's Advisory Committee on Genetics. Health, and Society. (2008). http://www4.od.nih.gov/oba/sacghs/reports/SACGHS-oversight-report.pdf.
69. Ray, T. (2010). Pharmacogenomics Reporter. http://www.genomeweb.com/ dxpgx/draft-bill-proposes-fda-create-new-division-review-advanced-personalized- diagnos.
70. FDA. (2009). Device Classification http://www.fda.gov/MedicalDevices/ DeviceRegulationandGuidance/Overview/ClassifyYourDevice/default.htm.
71. FDA, Center for Devices and Radiological Health, and Center for Biologics Evaluation and Research. (2010). Guidance for Industry and FDA Staff: In Vitro Diagnostic (IVD) Device Studies - Frequently Asked Questions. http://www.fda.gov/downloads/MedicalDevices/DeviceRegulationandGuidance/ GuidanceDocuments/UCM071230.pdf.